Board of Directors
Dr. Lawrence W. Greer
Dr. Greer is the Senior Managing Partners at Greer Capital Advisors LLC and began venture and private equity investing in 1986 following a 14 year period as a private dental practitioner in Birmingham, AL. From 1986-1989 he served as a self-employed consultant assisting local venture projects with business plan preparation, strategic planning, sourcing of debt and equity financing and operational oversight.
In September 2002, Dr. Greer founded Greer Capital Advisors, LLC and directed the raise of the S.C.O.U.T. Healthcare Fund, LP as it General Partner. He presently serves on the Advisory Committee of the New Virginia Capital Partners Fund, LP and the Investment Committee of the Whitecap Alabama Growth Fund I and II. He serves as General Partner to the Birmingham Technology Fund, LLC which he raised in 2006. Dr. Greer also serves as Chairman of the Audit Committee of Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX). Dr. Greer holds a B.S. from Tulane University, D.D.S. from Emory University and an M.B.A. from Emory University.
Dr. C. Lloyd Nix
Dr. Nix retired in 1999 from a successful dentistry practice of 36 years in Decatur, Alabama. He obtained a BS degree from Auburn University in 1959. After obtaining a DMD from the University of Alabama at Birmingham in 1963, he served as a Captain in the U.S. Air Force for two years prior to starting his dental practice. Dr. Nix has served as a director for First American Bank and Alabama National Bank.
Dr. Nix is also a member of the Auburn University Foundation Board and the Auburn University National Campaign Board. He previously served as a board member of the Alabama Institute Foundation for Deaf and Blind as well as Chairman of the Auburn University Research Advisory Board.
Gordon M. Sherman
Gordon Sherman is retired from 43-years of service to the military and federal government and is currently a principal at Lamon Sherman Consulting LLC, director with One Georgia Bank and director of Government Benefits and Information Services, Inc.
During the last 23 years of his career, Sherman was the southeast regional commissioner of the Social Security Administration. He was responsible for the $70 billion annual program including a network of 300 offices with a staff of more than 12,000 federal and state employees. Other capacities in which he presently serves include director of Lenbrook Foundation, Inc., a continuing care retirement community in Atlanta; director of the Auburn University Foundation; and a fellow in the National Academy of Public Administration.
Anton V. Vincent
Anton Vincent is currently the president of the General Mills Snacks division and has held this position since 2014. Previously, he led General Mills’ Frozen Foods division beginning in 2012. Vincent has been a corporate officer with General Mills since 2006, and he became a division president in 2010. During the 2001 acquisition of The Pillsbury Company, Vincent was a key member of the mergers and acquisitions team. Formerly, Vincent led a private equity group to purchase the Applebee’s franchises in western Tennessee, northern Mississippi and eastern Arkansas, serving as the firm’s managing partner.
Vincent is an active member of the General Mills community. He was a founding member of the employee Black Champions Network. He received the 2009 General Mills Champions Award for business impact and the 2011 General Mills Vanguard Award for his volunteer work.
Samuel M. Lawrence
Mr. Lawrence is the Chief Executive Officer and Co-Founder of CytoViva, Inc. Mr. Lawrence led the development of the core, patented optical illumination technology which is the foundation for CytoViva’s products. He continues to lead all product development efforts as well as actively support the company’s sales efforts both domestically and internationally. Mr. Lawrence is also the CEO of Aetos Technologies, Inc., a technology development company located in Auburn, AL.
Prior to CytoViva, Mr. Lawrence was a Director at Boeing Commercial Airplanes in Seattle, WA where he led Supply Chain Transformation for the 737/757 Programs and was Factory Manager of the Interiors Responsibility Center. Prior to Boeing, Mr. Lawrence worked with Deloitte & Touche, LLC as a management consultant. Mr. Lawrence began his career in 1986 as an engineer on the Boeing Commercial Airplanes Aerodynamics Staff after graduating from Mississippi State University with a Bachelor of Science degree in Aerospace Engineering. He is co-inventor on two U.S. Patents for his work on innovative insulation materials for commercial airplanes.
Mr. Lawrence left Boeing in 1991 to continue his education at the Northwestern University Kellogg Graduate School of Management where he earned a Masters of Management in Manufacturing in 1993. Mr. Lawrence also completed the International Executive Programme at INSEAD (Fontainebleau, France/Singapore) in 2002.
John O. Lawrence
John O. Lawrence is the Chief Operating Officer and Co-Founder of CytoViva, Inc. Mr. Lawrence is a senior executive with extensive experience in start-up companies, as well as medium to large sized operations. Mr. Lawrence’s primary responsibilities include managing the company’s accounting, legal, administrative, human resources, facilities and information systems efforts. In addition to his role at CytoViva, Mr. Lawrence also serves as the Chief Operating Officer of Aetos Technologies, Inc and Eagle Aquaculture, Inc.
Prior to joining CytoViva and Aetos, Mr. Lawrence was Executive Director of Sales Systems and Operations at Andrx Laboratories in Weston, FL. Prior to Andrx, he served as Vice President of Redundant Networks in Jackson, MS with responsibilities for customer operations. Mr. Lawrence also previously served as Manager of Technical Support and Customer Service for SkyTel, then a subsidiary of MCI. Prior to SkyTel, Mr. Lawrence served as Assistant Director of Alumni and College Relations for Millsaps College in Jackson, MS. Mr. Lawrence holds a BLS degree in sociology and anthropology from Millsaps College.
Byron J. Cheatham
Mr. Cheatham has held senior leadership positions in startup technology firms since 1996 and joined CytoViva in 2005, leading the company’s world-wide market development effort. During this time, Mr. Cheatham has worked with hundreds of leading nanotechnology and pathogen research laboratories around the world implementing innovative optical and hyperspectral imaging solutions.
Previously, Mr. Cheatham served as chief marketing officer for startup Unity Communications, which experienced revenue growth of over $35mm during its first four years of operations. After Unity, Mr. Cheatham served as vice president of operations at Integrity Online, an internet service and software development company While at Integrity he led the successful transition to from dialup to broadband services, enabling sustained revenue growth and operational profitability for the company.
Mr. Cheatham’s prior experience also includes general management, product marketing and national accounts sales executive positions within Fortune 500 corporations. Mr. Cheatham is a graduate of Mississippi State University, where he received his BA degree in 1986 and began his career as a biochemistry research assistant.